BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 9, 2014
View Archived Issues
Discovery and characterization of a novel class of Gram-positive antibacterial compounds
Read More
U.S. researchers patent new lentiviral vectors for stem cell gene therapy
Read More
Idenix Pharmaceuticals reports data for nucleotide prodrug development program
Read More
Bristol-Myers Squibb discloses novel fibronectin domain-based fusion proteins
Read More
Novel anti-IAPP MAbs divulged by Neurimmune Holding
Read More
UCB and Weill Cornell Medical College establish strategic research alliance
Read More
Ventana Medical Systems signs companion diagnostic agreement with Genmab
Read More
Novartis presents results from phase III studies of secukinumab
Read More
Pfizer gains access to IntegraGen's molecular signature for hepatocellular carcinoma
Read More
ValiRx establishes joint venture with Tangent Reprofiling
Read More
NLRP3 inflammasome inhibitor efficacious in model of ischemia-reperfusion injury
Read More
TetraLogic Pharmaceuticals to acquire Shape Pharmaceuticals
Read More
Two vemurafenib prodrugs developed with improved bioavailability
Read More
Ledipasvir/sofosbuvir combination gets FDA priority review
Read More
AbbVie designs new 5-HT2C receptor agonists
Read More
Novel tricyclic antibacterials presented by the LLNL and Cubist Pharmaceuticals
Read More
AEM-28 enters phase I/II trial in refractory hypercholesterolemia
Read More
TRV-130 begins phase II for acute postoperative pain after bunionectomy
Read More
Phase I trial to examine teprotumumab for new indication of diabetic macular edema
Read More
Phase I data on LY-2874455 shows safety and a favorable pharmacokinetic profile
Read More
Ambit Biosciences begins phase III QUANTUM-R trial
Read More
Kadmon Corporation initiates phase II study of KD-025 for psoriasis
Read More
Oncolytics Biotech reports additional data from Reolysin trial in head and neck cancer
Read More
RaQualia expands joint research agreement with Asahi Kasei Pharma
Read More
Thomson Reuters and Children's Tumor Foundation collaborate on neurofibromatosis pathway maps
Read More
Genentech presents new MEK inhibitors for cancer
Read More